This is associated with enhanced phosphorylation of AKT and ERK upon VPA treatment of FLT3-ITD-expressing AML cells as it might be expected following translocation of FLT3-ITD to the cell membrane. This evidence concerns the gene FLT3 and acute myeloid leukemia.